T is a humanized IgG1 mAb that stops the cell cycle due to the protein kinase B phosphorylation inhibition process and it activates the antibody-dependent cell-mediated cytotoxicity process against HER2-overexpressed breast cancer tumors [12]. Here, ERBB2 is linked to breast carcinoma.